
Antitumour vaccines cannot cure established tumours. However, tumour cells engineered to release cytokines can halt progression to cancer by inhibiting the angiogenic phenotype of pretumoural cells and activating tumour-associated leukocytes, thus they might prove useful in immunizing those at risk of cancer.

